VESALIUS-CV

Objective

The purpose of this study is to assess the effect of lowering low-density lipoprotein cholesterol (LDL-C) with evolocumab on major cardiovascular events in subjects without a prior MI or stroke at high risk of a cardiovascular event.

National Clinical Trial (NCT) Number: 03872401

National Library of Medicine clinicaltrials.gov Website Address: https://clinicaltrials.gov/study/NCT03872401

Location: Essentia Health East

Research Study Categories

• Clinical Trials and Health Care Delivery Studies

Specialties

• Cardiology

Contact

Cardiology Clinical Trials at 866-839-4128, [email protected]